Retreatment with Restylane Lyft with Lidocaine for chin augmentation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates the safety of retreating the chin region with Restylane Lyft containing Lidocaine. Eligible adults 22 and older who want augmentation and correction of chin retrusion may participate if they meet the criteria and have no contraindicating allergies or prior facial surgeries. The trial takes place at three Galderma investigational sites in the United States. Participants will receive Restylane Lyft with Lidocaine as the retreatment and will be monitored for safety outcomes related to the procedure.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Males or non-pregnant, non-breastfeeding females, 22 years of age or older.
2. Intent to receive treatment for augmentation and correction of retrusion in the chin region.

Exclusion Criteria:

1. Known/previous allergy or hypersensitivity to any injectable hyaluronic acid (HA) gel or to gram positive bacterial proteins.
2. Known/previous allergy or hypersensitivity to local anesthetics, e.g. lidocaine or other amide-type anesthetics.
3. Previous or present multiple allergies or severe allergies, such as manifested by anaphylaxis or angioedema, or family history of these conditions.
4. Previous facial surgery (including facial aesthetic surgery and liposuction), below the level of the horizontal line from subnasale.
5. Any previous aesthetic procedures or implants.
6. Presence of any disease or lesions near or on the area to be treated.

Where it's running

• Galderma Investigational Site # 8680
  Westport, Connecticut, United States Recruiting
• Galderma Investigational Site # 8774
  Boynton Beach, Florida, United States Recruiting
• Galderma Investigational Site # 7030
  Coral Gables, Florida, United States Recruiting
• Galderma Investigational Site # 8682
  Coral Gables, Florida, United States Recruiting
• Galderma Investigational Site # 7042
  Atlanta, Georgia, United States Recruiting
• Galderma Investigational Site # 7118
  Nashville, Tennessee, United States Recruiting

Study contacts

• Study coordinator: Clinical Project Manager
• Email: clinical.studies@galderma.com
• Phone: 817-961-5000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Midface contour and volume in Chinese adults treated with Sculptra™ over long term

  This study tests whether Sculptra™ used in standard practice can safely improve midface fullness over about two years in Chinese adults who have previously received the treatment.

  Recruiting Galderma R&D · Guangzhou · NCT07891767

• Improve profile of the jawline using Restylane Shaype

  This study tests whether Restylane Shaype can improve jawline definition in adults of Chinese origin who want treatment for their jawline.

  Recruiting at 2 sites Galderma R&D · Beijing, Beijing Municipality and 5 other locations · NCT07805512

• Nemolizumab vs placebo in Chinese teens and adults with moderate-to-severe atopic dermatitis

  This study tests whether Nemolizumab can help moderate-to-severe atopic dermatitis in Chinese participants aged 12 and up, compared with a placebo.

  Recruiting Phase 3 Galderma R&D · Hangzhou, Zhejiang · NCT07762833

• Nemolizumab for infants with moderate-to-severe atopic dermatitis

  This study tests whether nemolizumab can be safely given to infants aged 6 to under 24 months to help manage moderate-to-severe eczema when topical treatments alone aren’t enough.

  Recruiting Phase 2 Galderma R&D · San Antonio, Texas · NCT07660835

• Skin changes after biostimulator (Sculptra) treatment seen with non-invasive imaging

  We will try Sculptra injections in women aged 45–65 with moderate-to-severe cheek wrinkles to see how their skin changes over three treatments using non-invasive imaging.

  Recruiting Galderma R&D · New York, New York · NCT07399028

• PLLA (Sculptra) effects on cheek skin across menopausal stages

  This study will test whether PLLA (Sculptra) injections change skin protein levels and improve cheek wrinkles in menopausal women.

  Recruiting at 2 sites Galderma R&D · Miami, Florida and 1 other locations · NCT07342400

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.